FDA authorizes Pfizer COVID-19 vaccine for adolescents

The Food and Drug Administration (FDA) gave the green light for the Pfizer-BioNTech coronavirus vaccine to be used in adolescents 12 to 15 years old, a move that will make millions more people eligible for a vaccine.

The highly anticipated decision is a key step toward ensuring middle and high schools can operate for full in-person learning next fall — and a major boon to parents concerned about the safety of summer activities.